查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604579

抗寄生蟲藥市場：按藥物類型、劑型、適應症、分銷管道、最終用戶分類 - 2025-2030 年全球預測

Antiparasitic Drugs Market by Drug Type (Anthelmintics, Antiprotozoals, Ectoparasiticides), Form (Injections, Oral Tablets/Capsules, Topical Creams), Indication, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年抗寄生蟲藥物市值為204億美元，預計到2024年將達到211.2億美元，複合年成長率為4.59%，到2030年將達到279.4億美元。

抗寄生蟲藥物對於人類和動物寄生蟲感染疾病的管理至關重要，並且在全球健康中發揮重要作用。這些治療劑的範圍從頻譜藥物到針對特定寄生蟲（如蠕蟲、原生動物和體外寄生蟲）的藥物，在治療和預防保健中發揮著至關重要的作用。瘧疾、利什曼原蟲症和血吸蟲病等疾病的流行證明了對這些藥物的需求，特別是在熱帶地區。最終用途廣泛，包括醫院、診所、製藥公司和農業部門。市場開拓的驅動力是意識的提高、醫療成本的上升以及藥物開發技術的進步。對新型療法的需求，包括植物來源抗寄生蟲藥物和解決抗藥性的下一代製劑，創造了顯著的機會。此外，由於畜牧業生產和寵物養殖活性化，獸用抗寄生蟲藥領域的重要性迅速增加，也提供了良好的前景。

主要市場統計
基準年[2023] 204億美元
預測年份 [2024] 211.2億美元
預測年份 [2030] 279.4億美元
複合年成長率（%） 4.59%

然而，該領域面臨嚴格的法規環境、某些抗寄生蟲藥物的潛在副作用以及在偏遠地區分發藥物的困難等限制。寄生蟲抗藥性的快速發展也是一個重大挑戰，需要持續的技術創新和研究。開創性的研究領域包括開發合成大麻素作為抗寄生蟲藥物、探索傳統藥用植物以及增強遞送系統（例如基於奈米顆粒的藥物載體）以提高功效並降低抗藥性風險。製藥公司、研究機構和全球衛生組織之間的合作對於解決這些障礙至關重要。

簡而言之，抗寄生蟲藥物市場是一個充滿活力的市場，既具有強勁的成長潛力，也面臨多方面的挑戰。希望利用目前商機的相關人員應專注於改進配方、改進診斷工具以及利用夥伴關係關係來滲透市場。隨著該領域的發展，平衡創新和可近性對於最大限度地提高對全球健康和市場永續性的影響仍然至關重要。

市場動態：揭示快速發展的抗寄生蟲藥物市場的關鍵市場洞察

供需的動態交互作用正在改變抗寄生蟲藥物市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球寄生蟲感染疾病的發生率和認知不斷提高
    • 政府對寄生蟲感染控制採取有利的措施
    • 加大研發投入
  • 市場限制因素
    • 藥物研發需要龐大資金
  • 市場機會
    • 多個監管機構核准的抗寄生蟲藥物迅速增加
    • 製造商推出新的抗寄生蟲藥
  • 市場挑戰
    • 與藥物相關的副作用和風險

波特的五力：駕馭抗寄生蟲藥物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解抗寄生蟲藥物市場的外部影響

外部宏觀環境因素在塑造抗寄生蟲藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解抗寄生蟲藥市場的競爭狀況

抗寄生蟲藥市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣抗寄生蟲藥物市場供應商績效評估

FPNV定位矩陣是評估抗寄生蟲藥物市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪抗寄生蟲藥物市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，抗寄生蟲藥市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球寄生蟲感染的發生率和認知增加
      • 政府首選的寄生蟲感染控制方法
      • 增加對研發活動的投資
    • 抑制因素
      • 藥物研發需要大量資金
    • 機會
      • 多個監管機構核准的抗寄生蟲藥物激增
      • 廠商介紹新型抗寄生蟲藥
    • 任務
      • 與藥物相關的副作用和風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按類型分類的抗寄生蟲藥市場

  • 驅蟲藥
  • 抗原蟲
  • 外寄生蟲劑
  • 寄生劑

第7章抗寄生蟲藥市場：依形式

  • 注射
  • 口服錠劑/膠囊
  • 外用霜

第8章以適應症分類的抗寄生蟲藥市場

  • 鑿
  • 腸道寄生蟲
  • 蝨子
  • 瘧疾
  • 疥瘡
  • 打鉤

第9章抗寄生蟲藥市場：依通路

  • 離線
  • 線上

第10章抗寄生蟲藥市場：依最終用戶分類

  • 居家護理設施
  • 醫院/診所
  • 獸醫診所

第11章美洲抗寄生蟲藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太抗寄生蟲藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲抗寄生蟲藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Adva Care Pharma
  • Algen Healthcare Ltd.
  • Amneal Pharmaceuticals LLC
  • Bayer AG
  • Ben Pharmaceuticals
  • Centurion Laboratories Private Limited
  • Cipla Ltd.
  • Consern Pharma Limited
  • Dr.Reddys Laboratories Inc.
  • F. Hoffmann-La Roche AG
  • Fredun Group
  • Garcia Life Sciences
  • Glaxosmithkline PLC
  • Healthy Life Pharma Private Limited
  • Ipca Laboratories
  • Jackson Laboratories Pvt Ltd.
  • Mankind Pharma
  • Merck KgaA
  • Novartis AG
  • Sanofi
  • Soigner Pharma by Arlak Biotech
  • Sriwalls Health Care
  • Taj Life Sciences Pvt. Ltd.
  • Weefsel Pharma
  • Zydus Group
Product Code: MRR-B16853777759

The Antiparasitic Drugs Market was valued at USD 20.40 billion in 2023, expected to reach USD 21.12 billion in 2024, and is projected to grow at a CAGR of 4.59%, to USD 27.94 billion by 2030.

Antiparasitic drugs, essential in managing parasitic infections in humans and animals, serve a critical role in global health. These medications range from broad-spectrum agents to those targeting specific parasites like helminths, protozoa, or ectoparasites, and are pivotal in both treatment and preventive healthcare. The necessity of these drugs is underscored by the high prevalence of diseases like malaria, leishmaniasis, and schistosomiasis, particularly in tropical regions. Applications span human and veterinary medicine, with end-use scope encompassing hospitals, clinics, pharmaceutical enterprises, and agrarian sectors. Market growth is driven by increased awareness, rising healthcare expenditure, and advances in drug development technologies. Notable opportunities arise from the demand for novel therapeutics, including plant-based antiparasitics and next-generation formulations addressing drug resistance. The burgeoning importance of the veterinary antiparasitic segment, precipitated by intensified livestock production and pet ownership, also presents lucrative prospects.

KEY MARKET STATISTICS
Base Year [2023] USD 20.40 billion
Estimated Year [2024] USD 21.12 billion
Forecast Year [2030] USD 27.94 billion
CAGR (%) 4.59%

However, the field faces constraints such as stringent regulatory environments, potential side effects of certain antiparasitic agents, and difficulties in drug distribution in remote areas. The rapid pace of drug resistance among parasites poses a significant challenge, necessitating continuous innovation and research. Pioneering areas for research include the development of synthetic cannabinoids as antiparasitics, exploration of traditional medicinal plants, and the enhancement of delivery systems like nanoparticle-based drug carriers to increase efficacy and reduce resistance risks. Collaborative efforts among pharmaceutical companies, research institutions, and international health organizations are imperative to address these hurdles.

In essence, the antiparasitic drugs market is dynamic, characterized by both robust growth potential and multifaceted challenges. Stakeholders seeking to capitalize on current opportunities should focus on advancing drug formulations, improving diagnostic tools, and leveraging partnerships for enhanced market penetration. As the field evolves, it remains crucial to balance innovation with accessibility to maximize impact on global health and market sustainability.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antiparasitic Drugs Market

The Antiparasitic Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence and awareness of parasite infection across the globe
    • Favorable government initiatives for parasite infection management
    • Increasing investment in research and development activities
  • Market Restraints
    • Requirement of huge capital for drug development
  • Market Opportunities
    • Surge in approvals for antiparasitic drugs from several regulatory authorities
    • Introduction of novel antiparasitic drugs by manufacturers
  • Market Challenges
    • Adverse effects and risks associated with the drugs

Porter's Five Forces: A Strategic Tool for Navigating the Antiparasitic Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antiparasitic Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antiparasitic Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antiparasitic Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antiparasitic Drugs Market

A detailed market share analysis in the Antiparasitic Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antiparasitic Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antiparasitic Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antiparasitic Drugs Market

A strategic analysis of the Antiparasitic Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antiparasitic Drugs Market, highlighting leading vendors and their innovative profiles. These include Adva Care Pharma, Algen Healthcare Ltd., Amneal Pharmaceuticals LLC, Bayer AG, Ben Pharmaceuticals, Centurion Laboratories Private Limited, Cipla Ltd., Consern Pharma Limited, Dr.Reddys Laboratories Inc., F. Hoffmann-La Roche AG, Fredun Group, Garcia Life Sciences, Glaxosmithkline PLC, Healthy Life Pharma Private Limited, Ipca Laboratories, Jackson Laboratories Pvt Ltd., Mankind Pharma, Merck KgaA, Novartis AG, Sanofi, Soigner Pharma by Arlak Biotech, Sriwalls Health Care, Taj Life Sciences Pvt. Ltd., Weefsel Pharma, and Zydus Group.

Market Segmentation & Coverage

This research report categorizes the Antiparasitic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Anthelmintics, Antiprotozoals, Ectoparasiticides, and Endoparaciticides.
  • Based on Form, market is studied across Injections, Oral Tablets/Capsules, and Topical Creams.
  • Based on Indication, market is studied across Fleas, Intestinal Parasites, Lice, Malaria, Scabies, and Ticks.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on End-User, market is studied across Home Care Facilities, Hospitals & Clinics, and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence and awareness of parasite infection across the globe
      • 5.1.1.2. Favorable government initiatives for parasite infection management
      • 5.1.1.3. Increasing investment in research and development activities
    • 5.1.2. Restraints
      • 5.1.2.1. Requirement of huge capital for drug development
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in approvals for antiparasitic drugs from several regulatory authorities
      • 5.1.3.2. Introduction of novel antiparasitic drugs by manufacturers
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects and risks associated with the drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antiparasitic Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Anthelmintics
  • 6.3. Antiprotozoals
  • 6.4. Ectoparasiticides
  • 6.5. Endoparaciticides

7. Antiparasitic Drugs Market, by Form

  • 7.1. Introduction
  • 7.2. Injections
  • 7.3. Oral Tablets/Capsules
  • 7.4. Topical Creams

8. Antiparasitic Drugs Market, by Indication

  • 8.1. Introduction
  • 8.2. Fleas
  • 8.3. Intestinal Parasites
  • 8.4. Lice
  • 8.5. Malaria
  • 8.6. Scabies
  • 8.7. Ticks

9. Antiparasitic Drugs Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Antiparasitic Drugs Market, by End-User

  • 10.1. Introduction
  • 10.2. Home Care Facilities
  • 10.3. Hospitals & Clinics
  • 10.4. Veterinary Clinics

11. Americas Antiparasitic Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Antiparasitic Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Antiparasitic Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adva Care Pharma
  • 2. Algen Healthcare Ltd.
  • 3. Amneal Pharmaceuticals LLC
  • 4. Bayer AG
  • 5. Ben Pharmaceuticals
  • 6. Centurion Laboratories Private Limited
  • 7. Cipla Ltd.
  • 8. Consern Pharma Limited
  • 9. Dr.Reddys Laboratories Inc.
  • 10. F. Hoffmann-La Roche AG
  • 11. Fredun Group
  • 12. Garcia Life Sciences
  • 13. Glaxosmithkline PLC
  • 14. Healthy Life Pharma Private Limited
  • 15. Ipca Laboratories
  • 16. Jackson Laboratories Pvt Ltd.
  • 17. Mankind Pharma
  • 18. Merck KgaA
  • 19. Novartis AG
  • 20. Sanofi
  • 21. Soigner Pharma by Arlak Biotech
  • 22. Sriwalls Health Care
  • 23. Taj Life Sciences Pvt. Ltd.
  • 24. Weefsel Pharma
  • 25. Zydus Group

LIST OF FIGURES

  • FIGURE 1. ANTIPARASITIC DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIPARASITIC DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ANTIPARASITIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. ANTIPARASITIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIPARASITIC DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIPARASITIC DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ENDOPARACITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ORAL TABLETS/CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY TOPICAL CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY FLEAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY INTESTINAL PARASITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY LICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY MALARIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY SCABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY TICKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY HOME CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. ANTIPARASITIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. ANTIPARASITIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023